Search clinical trials for: JUUL ENDS - Mint 3% nicotine strength
Total 15 results
-
Juul Labs, Inc.Battelle Memorial Institute; Los Angeles Clinical TrialsCompletedElectronic Cigarette UseUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, CigarettesNew Zealand
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CelerionCompletedTobacco Use | Smoking, Tobacco | Nicotine Dependence, Other Tobacco ProductUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, CigarettesUnited States
-
Duke UniversityGeorgetown University; University of MichiganWithdrawnSmoking | Cigarette Smoking | E-cigarette Use
-
Florida International UniversityCompletedElectronic Cigarette UseUnited States
-
Virginia Polytechnic Institute and State UniversityCompletedTobacco UseUnited States
-
Cheerain HK LimitedCompletedElectronic Cigarette UseUnited States
-
Juul Labs, Inc.CompletedTobacco Smoking | Electronic Cigarette UseUnited States
-
University of Wisconsin, MadisonUniversity of Illinois at Chicago; Penn State UniversityCompleted
-
Jiaxiang ChenActive, not recruiting
-
National Research Council, SpainCompleted
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingGliosarcoma | MGMT-Unmethylated GlioblastomaUnited States